PPIL6
gene geneOn this page
Also known as bA425D10.6MGC41939dJ919F19.1RSPH12
Summary
PPIL6 (peptidylprolyl isomerase like 6, HGNC:21557) is a protein-coding gene on chromosome 6q21, encoding Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 (Q8IXY8). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity.
Predicted to enable RNA polymerase II CTD heptapeptide repeat P3 isomerase activity and RNA polymerase II CTD heptapeptide repeat P6 isomerase activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in cytoplasm.
Source: NCBI Gene 285755 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 68 total
- MANE Select transcript:
NM_173672
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21557 |
| Approved symbol | PPIL6 |
| Name | peptidylprolyl isomerase like 6 |
| Location | 6q21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA425D10.6, MGC41939, dJ919F19.1, RSPH12 |
| Ensembl gene | ENSG00000185250 |
| Ensembl biotype | protein_coding |
| Entrez | 285755 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000417394, ENST00000424445, ENST00000440797, ENST00000447468, ENST00000518648, ENST00000520723, ENST00000521072, ENST00000524031, ENST00000897716, ENST00000897717, ENST00000897718, ENST00000961131, ENST00000961132, ENST00000961133
RefSeq mRNA: 4 — MANE Select: NM_173672
NM_001111298, NM_001286360, NM_001286361, NM_173672
CCDS: CCDS47466, CCDS5074, CCDS69169
Canonical transcript exons
ENST00000521072 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001296630 | 109431157 | 109431345 |
| ENSE00001306599 | 109436104 | 109436199 |
| ENSE00003490339 | 109426847 | 109426994 |
| ENSE00003558647 | 109419187 | 109419243 |
| ENSE00003573693 | 109427094 | 109427156 |
| ENSE00003655910 | 109400035 | 109400170 |
| ENSE00003701651 | 109390215 | 109392937 |
| ENSE00003896640 | 109440456 | 109440628 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 93.78.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.7093 / max 52.7769, expressed in 1038 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 74996 | 2.5623 | 1013 |
| 74997 | 0.0805 | 32 |
| 74998 | 0.0666 | 37 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 93.78 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 92.67 | gold quality |
| sperm | CL:0000019 | 88.15 | silver quality |
| right testis | UBERON:0004534 | 88.02 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 88.02 | silver quality |
| left testis | UBERON:0004533 | 87.83 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.39 | gold quality |
| testis | UBERON:0000473 | 85.18 | gold quality |
| cortical plate | UBERON:0005343 | 84.40 | gold quality |
| ventricular zone | UBERON:0003053 | 84.32 | gold quality |
| bronchial epithelial cell | CL:0002328 | 83.17 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 82.89 | gold quality |
| bronchus | UBERON:0002185 | 81.83 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.13 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.50 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 78.79 | silver quality |
| islet of Langerhans | UBERON:0000006 | 78.37 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.18 | gold quality |
| fallopian tube | UBERON:0003889 | 77.01 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 76.98 | gold quality |
| thyroid gland | UBERON:0002046 | 76.59 | gold quality |
| nucleus accumbens | UBERON:0001882 | 75.33 | gold quality |
| caudate nucleus | UBERON:0001873 | 75.26 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 75.25 | gold quality |
| tendon | UBERON:0000043 | 74.65 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.68 | gold quality |
| left ovary | UBERON:0002119 | 73.68 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.49 | gold quality |
| pancreas | UBERON:0001264 | 73.27 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10287 | yes | 26.19 |
| E-ANND-3 | yes | 8.49 |
| E-MTAB-9388 | yes | 7.40 |
| E-ENAD-17 | no | 88.05 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
82 targeting PPIL6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ppil6 | ENSDARG00000042157 |
| mus_musculus | Ppil6 | ENSMUSG00000078451 |
| rattus_norvegicus | Ppil6 | ENSRNOG00000043186 |
| drosophila_melanogaster | Cyp40 | FBGN0036020 |
| caenorhabditis_elegans | WBGENE00000885 |
Paralogs (22): PPIE (ENSG00000084072), PPIL2 (ENSG00000100023), PPIF (ENSG00000108179), PPWD1 (ENSG00000113593), NKTR (ENSG00000114857), PPIL4 (ENSG00000131013), PPIL1 (ENSG00000137168), PPIG (ENSG00000138398), CWC27 (ENSG00000153015), PPIB (ENSG00000166794), PPIC (ENSG00000168938), PPID (ENSG00000171497), PPIH (ENSG00000171960), PPIA (ENSG00000196262), PPIAL4G (ENSG00000236334), PPIL3 (ENSG00000240344), PPIAL4A (ENSG00000263353), PPIAL4H (ENSG00000270339), PPIAL4E (ENSG00000271567), PPIAL4F (ENSG00000279782), PPIAL4C (ENSG00000288867), PPIAL4D (ENSG00000289549)
Protein
Protein identifiers
Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 — Q8IXY8 (reviewed: Q8IXY8)
Alternative names: Cyclophilin-like protein PPIL6, Rotamase PPIL6
All UniProt accessions (5): B4DEK6, Q8IXY8, H0Y7C3, H0YAQ8, H0YC62
UniProt curated annotations — full annotation on UniProt →
Function. Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity.
Similarity. Belongs to the cyclophilin-type PPIase family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IXY8-1 | 1 | yes |
| Q8IXY8-2 | 2 | |
| Q8IXY8-3 | 3 |
RefSeq proteins (4): NP_001104768, NP_001273289, NP_001273290, NP_775943* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002130 | Cyclophilin-type_PPIase_dom | Domain |
| IPR029000 | Cyclophilin-like_dom_sf | Homologous_superfamily |
Pfam: PF00160
UniProt features (5 total): splice variant 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IXY8-F1 | 92.39 | 0.86 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9918481 | Dengue Virus-Host Interactions |
MSigDB gene sets: 65 (showing top):
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, GOMF_CIS_TRANS_ISOMERASE_ACTIVITY, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOMF_ISOMERASE_ACTIVITY, LU_EZH2_TARGETS_UP, FIGUEROA_AML_METHYLATION_CLUSTER_6_UP, REACTOME_INFECTIOUS_DISEASE, FOXD2_TARGET_GENES, FOXJ2_TARGET_GENES, HAND1_TARGET_GENES, NFKBIA_TARGET_GENES, SNIP1_TARGET_GENES, ZIM3_TARGET_GENES
GO Biological Process (1): protein peptidyl-prolyl isomerization (GO:0000413)
GO Molecular Function (3): peptidyl-prolyl cis-trans isomerase activity (GO:0003755), protein binding (GO:0005515), isomerase activity (GO:0016853)
GO Cellular Component (1): cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Dengue Virus Infection | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyl-proline modification | 1 |
| cis-trans isomerase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| binding | 1 |
| catalytic activity | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1634 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PPIL6 | SYF2 | O95926 | 532 |
| PPIL6 | ZBTB24 | O43167 | 474 |
| PPIL6 | RSPH3 | Q86UC2 | 464 |
| PPIL6 | ATAD5 | Q96QE3 | 449 |
| PPIL6 | RSPH14 | Q9UHP6 | 430 |
| PPIL6 | SLC67A2 | Q8NBP5 | 400 |
| PPIL6 | MTRES1 | Q9P0P8 | 377 |
| PPIL6 | PPIL4 | Q8WUA2 | 369 |
| PPIL6 | CFAP300 | Q9BRQ4 | 367 |
| PPIL6 | DNAJC27 | Q9NZQ0 | 357 |
| PPIL6 | LSAMP | Q13449 | 341 |
| PPIL6 | RFC4 | P35249 | 339 |
| PPIL6 | EYA4 | O95677 | 339 |
| PPIL6 | RSPH9 | Q9H1X1 | 330 |
| PPIL6 | CHURC1 | Q8WUH1 | 330 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SORBS3 | PPIL6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPIL6 | APPBP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BAG4 | PPIL6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BIVM | PPIL6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPIL6 | SORBS3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PPIL6 | BAG4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PPIL6 | APPBP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PPIL6 | BIVM | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): PPIL6 (Affinity Capture-MS), PPIL6 (Synthetic Lethality), PPIL6 (Two-hybrid), PPIL6 (Two-hybrid), PPIL6 (Two-hybrid), PPIL6 (Two-hybrid), PPIL6 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0AVT1, A0JMM9, A2RVS4, A3KMX8, A3KNL6, A6H630, A8MRP2, D2TN58, O74834, P0AE48, P0AE49, P0AE50, P0AE51, P35875, P38074, P41888, P54121, P87305, Q16P90, Q32LH7, Q4H4F0, Q4R526, Q58EM4, Q5SPB6, Q66I06, Q66KX0, Q6AXB1, Q6DJA3, Q6INN8, Q7L1T6, Q7TS68, Q84QC1, Q8GY54, Q8IU29, Q8IXY8, Q8RX87, Q8TEA1, Q9C5X8, Q9FIX1, Q9FIX2
Diamond homologs: A0A0R0H9T5, A2AR02, A8X8D0, B3A0R0, D4AY02, H2QII6, O43447, O49605, O49886, O55035, O93826, O94273, P0C1H7, P0C1I1, P0C1I3, P0C1I7, P0C1I8, P0C1I9, P0CP78, P0CP79, P14088, P14832, P18253, P21568, P21569, P22011, P23285, P24525, P25007, P25719, P26882, P30404, P30412, P30414, P30415, P34790, P35176, P35627, P45877, P48820
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1672 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:109400168:CAT:C | acceptor_gain | 1.0000 |
| 6:109400170:TC:T | acceptor_loss | 1.0000 |
| 6:109400171:C:A | acceptor_loss | 1.0000 |
| 6:109400171:C:CC | acceptor_gain | 1.0000 |
| 6:109400172:T:G | acceptor_loss | 1.0000 |
| 6:109419182:CATA:C | donor_loss | 1.0000 |
| 6:109419183:ATAC:A | donor_loss | 1.0000 |
| 6:109419184:TA:T | donor_loss | 1.0000 |
| 6:109419185:ACC:A | donor_loss | 1.0000 |
| 6:109419186:C:CA | donor_loss | 1.0000 |
| 6:109429731:C:A | donor_gain | 1.0000 |
| 6:109431179:G:C | donor_gain | 1.0000 |
| 6:109436102:AC:A | donor_gain | 1.0000 |
| 6:109436103:CC:C | donor_gain | 1.0000 |
| 6:109436208:C:CT | acceptor_gain | 1.0000 |
| 6:109441168:GCTG:G | donor_gain | 1.0000 |
| 6:109400029:ACAT:A | donor_loss | 0.9900 |
| 6:109400030:CAT:C | donor_loss | 0.9900 |
| 6:109400031:ATA:A | donor_loss | 0.9900 |
| 6:109400032:TA:T | donor_loss | 0.9900 |
| 6:109400033:A:AC | donor_gain | 0.9900 |
| 6:109400033:A:AG | donor_loss | 0.9900 |
| 6:109400033:AC:A | donor_gain | 0.9900 |
| 6:109400034:C:CC | donor_gain | 0.9900 |
| 6:109400034:C:CG | donor_loss | 0.9900 |
| 6:109400034:CC:C | donor_gain | 0.9900 |
| 6:109400166:TTCAT:T | acceptor_gain | 0.9900 |
| 6:109400167:TCAT:T | acceptor_gain | 0.9900 |
| 6:109400168:CATC:C | acceptor_gain | 0.9900 |
| 6:109400169:AT:A | acceptor_gain | 0.9900 |
AlphaMissense
2054 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:109426879:C:G | R200P | 0.994 |
| 6:109440503:C:A | G30W | 0.988 |
| 6:109400035:C:T | G275E | 0.987 |
| 6:109436133:A:G | W68R | 0.987 |
| 6:109436133:A:T | W68R | 0.987 |
| 6:109400036:C:A | G275W | 0.986 |
| 6:109400131:A:T | L243H | 0.986 |
| 6:109400037:A:C | F274L | 0.985 |
| 6:109400037:A:T | F274L | 0.985 |
| 6:109400039:A:G | F274L | 0.985 |
| 6:109426957:A:G | F174S | 0.984 |
| 6:109431263:A:G | L105P | 0.984 |
| 6:109436195:A:G | L47P | 0.984 |
| 6:109400041:G:T | A273D | 0.983 |
| 6:109400088:G:C | F257L | 0.983 |
| 6:109400088:G:T | F257L | 0.983 |
| 6:109400090:A:G | F257L | 0.983 |
| 6:109426862:A:G | W206R | 0.983 |
| 6:109426862:A:T | W206R | 0.983 |
| 6:109426956:A:C | F174L | 0.983 |
| 6:109426956:A:T | F174L | 0.983 |
| 6:109426958:A:G | F174L | 0.983 |
| 6:109440502:C:T | G30E | 0.983 |
| 6:109400089:A:G | F257S | 0.982 |
| 6:109440460:G:T | A44D | 0.982 |
| 6:109426959:A:C | N173K | 0.981 |
| 6:109426959:A:T | N173K | 0.981 |
| 6:109440461:C:G | A44P | 0.981 |
| 6:109440503:C:G | G30R | 0.980 |
| 6:109440503:C:T | G30R | 0.980 |
dbSNP variants (sampled 300 via entrez): RS1000056939 (6:109437362 G>A,T), RS1000218907 (6:109398829 A>G), RS1000232437 (6:109419387 C>G,T), RS1000299142 (6:109435703 T>A), RS1000315803 (6:109433070 T>C), RS1000415180 (6:109400868 T>G), RS1000559993 (6:109420893 T>A), RS1000595802 (6:109427559 G>C,T), RS1000652146 (6:109434570 C>T), RS1000664085 (6:109425767 A>G), RS1000727337 (6:109422158 G>T), RS1000786246 (6:109407249 T>C), RS1000901178 (6:109434573 T>C), RS1000923525 (6:109406936 A>G), RS1000982062 (6:109440564 G>A,C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000175_27 | Height | 4.000000e-06 |
| GCST002647_58 | Height | 2.000000e-17 |
| GCST90002385_566 | High light scatter reticulocyte count | 5.000000e-18 |
| GCST90002386_108 | High light scatter reticulocyte percentage of red cells | 5.000000e-11 |
| GCST90002388_2 | Lymphocyte count | 5.000000e-10 |
| GCST90002389_333 | Lymphocyte percentage of white cells | 6.000000e-13 |
| GCST90002399_304 | Neutrophil percentage of white cells | 2.000000e-12 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007986 | reticulocyte count |
| EFO:0004587 | lymphocyte count |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0007990 | neutrophil percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases methylation, affects cotreatment | 3 |
| bisphenol A | decreases expression, decreases methylation, increases methylation | 2 |
| Air Pollutants | increases abundance, increases expression | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Tretinoin | decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression | 2 |
| trichostatin A | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Rosiglitazone | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Phenobarbital | increases expression | 1 |
| Rotenone | increases expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.